SAN CARLOS, Calif.--September 23, 2026--Glycomine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to GLM101 for the treatment of phosphomannomutase 2 congenital...
Scott Weiner to be panelist at PricewaterhouseCooper's "Shaking the Money Tree" event at the Embassy Suites Hotel in Cary, NC
News | 11. 15. 2007
